Stereotaxis, Inc. (STXS)
Dopo ore:
| Chiusura precedente | 1,8800 |
| Aperto | 1,9100 |
| Denaro | 1,8500 x 1100 |
| Lettera | 1,9300 x 900 |
| Min-Max giorno | 1,8500 - 1,9100 |
| Intervallo di 52 settimane | 1,5500 - 3,8100 |
| Volume | |
| Media Volume | 181.255 |
| Capitalizzazione | 138,463M |
| Beta (5 anni mensile) | 1,73 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,1100 |
| Prossima data utili | 08 mag 2023 - 12 mag 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 5,86 |
- GlobeNewswire
Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders. “Advancing patient care
- GlobeNewswire
Stereotaxis Reports 2022 Full Year Financial Results
ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2022. “This year is poised to be an important and exciting year for Stereotaxis, as we bring multiple strategic innovations to key regulatory and commercial milestones,” said David Fischel, Chairman and CEO. “This transition to a new produc
- GlobeNewswire
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Cowen 43rd Annual Health Care Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion with Josh Jennings, Cowen’s Managing Director & Senior Research Analyst, on Monday, March 6, 2023, at 11:10 am ET. M
